Obesity Market Share Analysis, Growth Opportunities, Current Treatment Practices, Emerging Therapies, Epidemiology, and Key Companies

“Obesity Market”

DelveInsight’s “Obesity Market Insights, Epidemiology, and Market Forecast-2032“ report delivers an in-depth understanding of the obesity, historical and forecasted epidemiology as well as the obesity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Obesity market report provides current treatment practices, emerging drugs, Obesity market share of the individual therapies, and current and forecasted obesity market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current obesity treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of opportunities. It assesses the underlying potential of the market.

Key Highlights from the Obesity Market Report:

• An increase in the market size of Obesity is anticipated for the study period, 2019–2032, owing to the expected approval of emerging therapies, improved understanding, and growing awareness of FECD in the 7MM.
• The total Obesity prevalence in the 7MM was estimated to be approximately 17,499,877 cases in the year 2021, which are expected to increase by 2032.
• In 2021, among the 7MM, the US had the highest total prevalent cases of Obesity with about 6,450,491 cases, while Spain had the lowest cases in 2021.
• Some of the key companies proactively working in the Obesity therapeutic market include Kowa Pharmaceutical, Trefoil Therapeutics, Emmecell, Santen, and many more.

Learn more about the key trends and developments driving the market growth @ Obesity Market Landscape 

Obesity Overview

Obesity is recognized as a chronic or noncommunicable disease, which is a complex, multifactorial phenotype, affecting, along with overweight, primarily associated with excess adiposity, or body fatness which can manifest metabolically and not just with respect to the size of the body. Obesity proceeds from an energy imbalance between calories consumed and the calories expended, creating an energy surplus and a state of positive energy balance resulting in excess body weight. Hereditary factors – genetics, family history, racial/ethnic differences – and particular socioeconomic and sociocultural milieus have been shown to affect the risk of obesity.As per the World Health Organization (WHO), obesity is classified on the basis of body mass index (BMI). BMI is further evaluated in terms of fat distribution via the waist-hip ratio and total cardiovascular risk factors. In children, a healthy weight varies according to age and sex. Obesity results from an interaction between an individual’s genetic predisposition to weight gain and environmental influences. The severe forms and majority of the early-onset monogenic forms of obesity have aroused from gene mutations in the leptin-melanocortin axis, particularly LEPR encoding for the leptin receptor, POMC (pro-opiomelanocortin), MC4R (melanocortin-4 receptor), NTRK2 (tropomyosin receptor kinase B receptor), and SIM1 (single-minded 1 transcription factor).

Obesity Epidemiology Segmentation

The Obesity proffers epidemiological analysis for the study period 2019-32 in the 7MM segmented into-

• Obesity Total prevalent cases
• Obesity patients seeking help
• Obesity total treated cas

Obesity Market

To learn more about the development in the therapeutics market @ Obesity Market Analysis

Obesity Market Drivers

• Increasing prevalence of childhood and adult obesity
• Rich emerging pipeline assets driving the R&D
• Private and government organizations have taken certain initiatives to raise awareness about the disease.

Obesity Market Barriers

• Negative implications impairing the quality of life
• Lack of sufficient knowledge and risk perception 
• Socioeconomic and Psychosocial burden of obesity.

Obesity Key Companies 

• Novo Nordisk
• Eli Lilly and Company
• Eurofarma Laboratorios S.A. 
• And many others 

Obesity Key Therapies

• Semaglutide oral
• Tirzepatide
• Sibutramine/Topiramate 
• And many others.

Discover more about therapies set to grab major market share @ Obesity Market Report Outlook

Table of Contents

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/